IL-35 expression increases tumorigenesis by increasing infiltration of CD11b+Gr1+ myeloid cells and thus increasing tumor angiogenesis, as well as a decrease in the numbers and effector functions of CD4+ and CD8+ TIL. This evidence concerns the gene CD4 and neoplasm.